Similar articles

• Histologic deterioration and more flares: the case against azathioprine plus methylprednisolone in the treatment of proliferative lupus nephritis.

  Chan TM. Chan TM. Arthritis Rheum. 2007 Mar;56(3):702-4. doi: 10.1002/art.22448. Arthritis Rheum. 2007. PMID: 17328038 No abstract available.
• A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.

  Moroni G, Doria A, Mosca M, Alberighi OD, Ferraccioli G, Todesco S, Manno C, Altieri P, Ferrara R, Greco S, Ponticelli C. Moroni G, et al. Clin J Am Soc Nephrol. 2006 Sep;1(5):925-32. doi: 10.2215/CJN.02271205. Epub 2006 Jun 28. Clin J Am Soc Nephrol. 2006. PMID: 17699309 Clinical Trial.
• [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].

  Petrović R, Stojanović R, Novicić-Sasić D, Dimitrijević J, Pavlović S, Stojković D, Palić-Obradović D, Stevanović G, Prodanović S. Petrović R, et al. Srp Arh Celok Lek. 2002 Aug;130 Suppl 3:19-25. Srp Arh Celok Lek. 2002. PMID: 12583309 Serbian.
• This house believes that low-dose intravenous cyclophosphamide is superior to standard high-dose regimes for treatment of lupus nephritis.

  Gorman C, Bhatia A, Rahman A. Gorman C, et al. Rheumatology (Oxford). 2005 Mar;44(3):398-401. doi: 10.1093/rheumatology/keh440. Epub 2004 Oct 19. Rheumatology (Oxford). 2005. PMID: 15494351 Review. No abstract available.
• How did cyclophosphamide become the drug of choice for lupus nephritis?

  Bargman JM. Bargman JM. Nephrol Dial Transplant. 2009 Feb;24(2):381-4. doi: 10.1093/ndt/gfn640. Epub 2008 Dec 4. Nephrol Dial Transplant. 2009. PMID: 19056783 Review. No abstract available.